NCT04364984View on ClinicalTrials.gov

ARB, ACEi, DRi Effects on COVID-19 Course Disease

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

July 24, 2021

Study Completion Date

August 1, 2021

Conditions
HypertensionCOVID-19
Interventions
DRUG

Angiotensin converting enzyme inhibitor

routine drug intake

DRUG

Angiotensin Receptor Blockers

routine drug intake

DRUG

Direct renin inhibitor

routine drug intake

Trial Locations (1)

01014

Medical Practice Prof D.Ivanov, Kiev

All Listed Sponsors
lead

Medical Practice Prof D. Ivanov

OTHER

NCT04364984 - ARB, ACEi, DRi Effects on COVID-19 Course Disease | Biotech Hunter | Biotech Hunter